BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0013
-0.00013 (-9.09%)
At close: Jul 6, 2026
BioAdaptives Employees
BioAdaptives had 1 employees as of March 31, 2026. The number of employees did not change compared to the same quarter last year.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
$23,792
Profits / Employee
-$1,471,848
Market Cap
15.61K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Jun 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Mar 31, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Sep 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Jun 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Mar 31, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Dec 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Sep 30, 2023 | 6 | 0 | - | 3 | 3 |
| Jun 30, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Mar 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Dec 31, 2022 | 7 | 0 | - | 3 | 4 |
| Sep 30, 2022 | 6 | -1 | -14.29% | 3 | 3 |
| Jun 30, 2022 | 7 | - | - | 3 | 4 |
| Mar 31, 2022 | 7 | - | - | 3 | 4 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
BioAdaptives News
- 11 days ago - BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity - GlobeNewsWire
- 6 weeks ago - BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery - GlobeNewsWire
- 2 months ago - BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle - GlobeNewsWire
- 9 months ago - BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing - GlobeNewsWire
- 11 months ago - BioAdaptives' MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety - GlobeNewsWire
- 1 year ago - BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience - GlobeNewsWire
- 1 year ago - BioAdaptives Announces National Launch of Pawpa™ Regen - GlobeNewsWire
- 1 year ago - BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements - GlobeNewsWire